Trevena
Trevena is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of CNS.
Business Model:
Revenue: $378k
Employees: 11-50
Industries / Tags:
Detailed Trevena Information
Geographic Data
Address: 955 Chesterbrook Blvd
City: Chesterbrook
State: PA
Zip: 19087
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$2M
Raised Total:$263M
Social
Metrics
3,519,838Website Global Rank
3,274Website Monthly Traffic
Twitter Followers
Description
Trevena is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of CNS.
Contact Phone:
+16103548840
Contact Email:
Trevena went public on 1/31/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/31/2014
IPO Valuation:
$291M
Ticker Symbol:
TRVN
IPO Price:
$4/share
Amount Raised:
$40M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2014 | IPO | $64.8M | 12/2011 | Grant | 1 | $205k |
Michael J. Fox Foundation Michael J. Fox Foundation |
5/2013 | Series C | $60M | 8/2020 | Post-IPO Equity | $50M | 4/2015 | Post-IPO Equity | $40M | 8/2011 | Grant | $10M | 3/2008 | Series A | 4 | $24M |
Polaris Partners New Enterprise Associates HealthCare Ventures Alta Partners Polaris Partners New Enterprise Associates HealthCare Ventures Alta Partners |
11/2009 | Grant | 1 | $7.7M |
National Institutes of Health (NIH) National Institutes of Health (NIH) |
9/2014 | Post-IPO Debt | 2 | $35M |
Square 1 Bank Oxford Finance LLC Square 1 Bank Oxford Finance LLC |
7/2022 | Post-IPO Equity | $2M | 8/2020 | Post-IPO Equity | - | 1/2019 | Post-IPO Equity | $10M | 12/2015 | Post-IPO Equity | $75M | 9/2015 | Post-IPO Equity | $72.9M | 9/2015 | Post-IPO Equity | $72.9M | 11/2014 | Post-IPO Equity | $45M | 5/2013 | Series C | 1 | $60M |
Forest Laboratories Forest Laboratories Forest Laboratories |
7/2010 | Series B | 4 | $35M |
Polaris Partners New Enterprise Associates HealthCare Ventures Alta Partners Polaris Partners New Enterprise Associates HealthCare Ventures Alta Partners |
8/2020 | Post-IPO Equity | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
